Eric Crombez
Director at Abeona Therapeutics Inc. (ABEO); Evp And Chief Medical Officer at Ultragenyx Pharmaceutical Inc. (RARE)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $396K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 15SEC | ABEOAbeona Therapeutics Inc. | Sell Plan | 26,14337,313 held (−41%) | $5.53 | $145K | -19.9% |
| May 6SEC | RAREUltragenyx Pharmaceutical Inc. | Sell | 344111,189 held (−0%) | $24.96 | $9K | -41.7% |
| Mar 3SEC | RAREUltragenyx Pharmaceutical Inc. | Sell | 7,02976,301 held (−8%) | $22.80 | $160K | -36.2% |
| Feb 2SEC | ABEOAbeona Therapeutics Inc. | Sell | 16,28463,456 held (−20%) | $5.09 | $83K | -13.0% |
- Sell
Director Eric Crombez sold $145K of ABEO at $5.53 — cuts the stake by 41%; pre-scheduled 10b5-1 plan sale.